U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H5O7.Ga
Molecular Weight 256.0282
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GALLIUM CITRATE GA-67

SMILES

C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ga+3]

InChI

InChIKey=YEEGWNXDUZONAA-RYDPDVNUSA-K
InChI=1S/C6H8O7.Ga/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3/i;1-3

HIDE SMILES / InChI

Molecular Formula C6H5O7
Molecular Weight 189.1
Charge -3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Ga
Molecular Weight 66.9282
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Gallium citrate Ga 67 is the citrate salt of the radioisotope gallium Ga 67. Although the mechanism is unknown, gallium Ga 67 concentrates in lysosomes and is bound to a soluble intracellular protein in certain viable primary and metastatic tumors and focal sites of inflammation, allowing scintigraphic localization. Ga-67 scintigraphy (GS) cannot differentiate between tumor and acute inflammation. Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
GALLIUM CITRATE GA 67

Approved Use

Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Launch Date

2.01052799E11
Primary
GALLIUM CITRATE GA 67

Approved Use

Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Launch Date

2.01052799E11
Primary
GALLIUM CITRATE GA 67

Approved Use

Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Launch Date

2.01052799E11

Sample Use Guides

DOSAGE AND ADMINISTRATION: The recommended adult (70 kg) dose of Gallium Citrate Ga 67 Injection is 74-185 MBq (2-5 mCi). Gallium Citrate Ga 67 Injection is intended for intravenous administration only
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Jun 25 23:38:00 UTC 2021
Edited
by admin
on Fri Jun 25 23:38:00 UTC 2021
Record UNII
4LJK511Z86
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GALLIUM CITRATE GA-67
ORANGE BOOK  
Common Name English
GALLIUM CITRATE GA 67 [USAN]
Common Name English
GALLIUM CITRATE, GA-67
Common Name English
GALLIUM-67 CITRATE
Common Name English
1,2,3-PROPANETRICARBOXYLIC ACID, 2-HYDROXY-, GALLIUM-(SUP 67)GA (1:1) SALT
Common Name English
1,2,3-PROPANETRICARBOXYLIC ACID, 2-HYDROXY-, GALLIUM-67GA (1:1) SALT
Common Name English
GALLIUM GA-67 CITRATE
Common Name English
GALLIUM ((SUP 67)GA) CITRATE
Common Name English
GALLIUM CITRATE,GA-67
VANDF  
Common Name English
GALLIUM CITRATE,GA-67 [VANDF]
Common Name English
GALLIUM CITRATE GA 67
MI   USAN   USP  
USAN  
Official Name English
GALLIUM-(SUP 67)GA CITRATE (1:1)
Common Name English
GALLIUM CITRATE GA-67 [ORANGE BOOK]
Common Name English
GALLIUM (67GA) CITRATE [INN]
Common Name English
GALLIUM (67 GA) CITRATE
WHO-DD  
Common Name English
GALLIUM (67 GA) CITRATE [WHO-DD]
Common Name English
GALLIUM (67 GA) [WHO-DD]
Common Name English
GALLIUM (67GA) CITRATE
INN  
INN  
Official Name English
GALLIUM CITRATE GA 67 [MI]
Common Name English
GALLIUM-67GA CITRATE (1:1)
Common Name English
GALLIUM 67 CITRATE
Common Name English
GALLIUM CITRATE GA 67 [USP]
Common Name English
Classification Tree Code System Code
WHO-VATC QV09HX01
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
NCI_THESAURUS C1446
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
NDF-RT N0000000205
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
NDF-RT N0000177914
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
WHO-ATC V09HX01
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
Code System Code Type Description
RXCUI
272758
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
EPA CompTox
41183-64-6
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
ECHA (EC/EINECS)
255-248-4
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
LACTMED
Gallium Citrate Ga 67
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
MERCK INDEX
M5649
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY Merck Index
CAS
41183-64-6
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
DRUG CENTRAL
4560
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
RXCUI
1546372
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
ALTERNATIVE
DRUG BANK
DB06784
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
EVMPD
SUB02307MIG
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
PUBCHEM
65430
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
ChEMBL
CHEMBL2110553
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
EVMPD
SUB07873MIG
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
INN
3744
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
FDA UNII
4LJK511Z86
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
NCI_THESAURUS
C47547
Created by admin on Fri Jun 25 23:38:01 UTC 2021 , Edited by admin on Fri Jun 25 23:38:01 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY